• Home
  • About
    • Overview
    • Core technologies
      • Invivotech
      • Echotech
      • Bloodsim
    • Team
    • Board of Directors
    • Investors
  • Products
    • Neurovascular
      • Unruptured Aneurysm
      • Ischemic Stroke
    • Cardiovascular
      • LAA Closure
      • Transseptal Training
  • News
    • Press releases
    • Events
      • Neurovascular
      • Cardiovascular
  • Contact


PRESS RELEASES

2021
2020
2019
2018

February 1, 2021

Biomodex Teams Up with Physicians at Three of the World’s Top Medical Centers to Develop a Cutting-Edge Training Solution for Treatment of Ischemic Stroke

> Read more

January 14, 2021

BIOMODEX Expands Product Offerings with Innovative Transseptal Puncture Training Solution

> Read more

December 17, 2020

BIOMODEX Announces Presentation of Data at SFNR 2020 Highlighting Benets of Patient-Specic Rehearsals in Complex Unruptured Intracranial Aneurysms

> Read more

December 3, 2020

BIOMODEX Names Bill Perusek as Vice President of U.S. Sales

> Read more

November 17, 2020

BIOMODEX Receives ISO 13485 Certification

> Read more

July 1, 2020

BIOMODEX Announces Results of First Clinical Study Using Patient-Specific Brain Aneurysm Models for Pre-Procedural Rehearsals

> Read more

June 2, 2020

BIOMODEX Appoints MedTech Industry Veteran Karl Schweitzer as New Board Chair

> Read more

February 8, 2019

BIOMODEX Celebrates Grand Opening of New U.S. Corporate Headquarters and 3D Printing Lab

> Read more

October 4, 2018

BIOMODEX Announces New Training Solution for Left Atrial Appendage Closure (LAACS)

> Read more

June 7, 2018

BIOMODEX Raises an Additional $15M in Series A Funding

> Read more

AMERICAS:
300 Crown Colony Drive, Suite 504
Quincy, MA 02169 - USA

EMEA:
2 rue de la Roquette
75011 Paris - France

Supported by

Logo Dassault Systèmes
in
Legal notice Cookies Policy

2021 Biomodex®

×